Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Gilead Sciences, Inc. (NASDAQ: GILD)
GILD Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
4.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
24%
GILD Stock Analysis
GILD
PE Ratio:
17.6
GILD
PEG Ratio:
Not Available
GILD
Forward EPS Growth (12 month):
0.00%
GILD
PS Ratio:
5.4
GILD
PSG Ratio:
0.9
GILD
Forward Revenue Growth (12 month):
6.30%
GILD Articles
No data was found